Kythera Biopharmaceuticals Inc (KYTH) Return on Investment ROI from the second quarter of 2015 to second quarter of 2014 and for the year 2015, average high and low, overall ranking from Jun 30 2015 to Jun 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kythera Biopharmaceuticals Inc  (KYTH)


Kythera Biopharmaceuticals Inc's ROI from its second quarter of 2015 to the second quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kythera Biopharmaceuticals Inc's ROI in the second quarter of 2015?
Kythera Biopharmaceuticals Inc recorded a cumulative net loss of $-113 million during 12 months ending in the second quarter of 2015, resulting in a negative return on investment (ROI) of -81.25%.

Within the Healthcare sector 326 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2015 from 0 to 3833.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Investment Change TTM 18.76 % 27.9 % 41.44 % 122.56 % 331.42 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 172 196 83 104 125
Return On Investment (TTM) -81.25 % -74.84 % -119.52 % -95.21 % -98.03 %
KYTH's Overall Ranking # 3833 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 9.26 % 11.85 % -13.86 % 12.82 % 17.66 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -113 -95 -136 -125 -114

KYTH Company Profile >> Back to KYTH Roi Comparisons >> See Annual KYTH Return On Investment



Return On Investment KYTH's Ranking
Within: No.
Industry # 124
Sector # 327
Overall # 3833

Return On Investment Statistics
High Average Low
-64.71 %
-104.6 %
-204.2 %
(Dec 31 2013)   (Jun 30 2013)







Financial Statements
Kythera Biopharmaceuticals Inc's II. Quarter Investments $ 172 Millions KYTH's Balance sheet
Kythera Biopharmaceuticals Inc's II. Quarter Income $ -37 Millions Quarterly KYTH's Income Statement
KYTH's Income by Division See KYTH's Income by Division


KYTH Annual Return On Investment (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012

Total Investments in Millions 83 156 72 0 0
Y / Y Investment Growth -46.87 % 117.39 % - - -
Net Income in Millions -136 -52 -37 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -163.8 % -33.31 % -51.34 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KYTH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KYTH's Competitors
Subscribers only: Roi for Kythera Biopharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for KYTH's Customers

Other Ratios
KYTH's Roa KYTH's Inventory Turnover Ratio KYTH's Growth Rates KYTH's Dividend Statistics
KYTH's Profitability Ratios KYTH's Asset Turnover Ratio KYTH's Dividend Growth
KYTH's Roe KYTH's Valuation Ratios KYTH's Financial Strength Ratios KYTH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2015, within Healthcare Sector ROI

Date modified: 2026-09-26T07:14:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.